Children's National Hospital

TeleRare Health™ Announces Launch of National Virtual Clinic for Rare Disease Patients

Retrieved on: 
화요일, 4월 30, 2024

MINNEAPOLIS, April 30, 2024 /PRNewswire/ -- 8:00a (CET) April 30, 2024 - TeleRare Health™ launched today, a virtual clinic for Rare Disease patients and their families.

Key Points: 
  • MINNEAPOLIS, April 30, 2024 /PRNewswire/ -- 8:00a (CET) April 30, 2024 - TeleRare Health™ launched today, a virtual clinic for Rare Disease patients and their families.
  • TeleRare Health aims to be the premier provider of virtual care for rare and genomic disease nationwide, envisioning a world where all patients have access to cutting edge diagnostics, treatments, and specialists.
  • "Significant breakthroughs have occurred in the management of rare disease," said Alex Katz, MD, medical geneticist and Chief Medical Officer of TeleRare Health.
  • We're overdue for a virtual clinic for the millions of Americans with rare disease conditions, and TeleRare Health's launch is cause for optimism.

IHI and The DAISY Foundation™ Honor Extraordinary Nurses in Patient Safety

Retrieved on: 
화요일, 4월 23, 2024

The Institute for Healthcare Improvement (IHI) and The DAISY Foundation today announced the recipients of the 10th annual DAISY Award® for Extraordinary Nurses in Patient Safety.

Key Points: 
  • The Institute for Healthcare Improvement (IHI) and The DAISY Foundation today announced the recipients of the 10th annual DAISY Award® for Extraordinary Nurses in Patient Safety.
  • Presented in collaboration with IHI, the DAISY Awards will be bestowed at the IHI Patient Safety Congress 2024 , which will take place May 14-16 in Orlando, Florida.
  • Each year, The DAISY Award for Extraordinary Nurses in Patient Safety celebrates nurses and clinical teams for their commitment to patient and workforce safety in the delivery of compassionate care for patients and families.
  • “All of us at IHI and The DAISY Foundation commend the awardees for being caring and compassionate nurses, and stewards of patient and workforce safety.”
    The DAISY Award for Extraordinary Nurses in Patient Safety is supported by a generous grant from Baxter , a global provider of clinical technology and patient safety solutions.

Orange County Pediatric Dentistry Adds New Location, Lip & Tongue Tie at OCPD

Retrieved on: 
화요일, 4월 23, 2024

MONROE, N.Y., April 23, 2024 /PRNewswire-PRWeb/ -- Orange County Pediatric Dentistry is excited to announce the opening of its new location, Lip & Tongue Tie at OCPD. Located next door to the existing pediatric dental practice, the new branch focuses specifically on lip and tongue tie treatment, providing a dedicated space for this in-demand service. There is also a new website for the location containing information about the specific services offered: https://www.tonguetieoc.com.

Key Points: 
  • Orange County Pediatric Dentistry is excited to announce the opening of its new location, Lip & Tongue Tie at OCPD.
  • MONROE, N.Y., April 23, 2024 /PRNewswire-PRWeb/ -- Orange County Pediatric Dentistry is excited to announce the opening of its new location, Lip & Tongue Tie at OCPD.
  • The existing practice, Orange County Pediatric Dentistry, will remain open and operational alongside the new Lip & Tongue Tie at the OCPD office, continuing to provide comprehensive pediatric dental care for children of all ages.
  • Lip & Tongue Tie at OCPD provides the following services:
    The use of dental lasers in frenectomy procedures is a common practice by trained dental professionals.

Credence President and CEO Recognized with Federal 100 Award

Retrieved on: 
수요일, 4월 17, 2024

VIENNA, Va., April 17, 2024 /PRNewswire/ -- Credence is proud to share that our President and CEO, Prashant Gaur, has been named to the Federal 100, which recognizes excellence in federal IT.

Key Points: 
  • VIENNA, Va., April 17, 2024 /PRNewswire/ -- Credence is proud to share that our President and CEO, Prashant Gaur, has been named to the Federal 100, which recognizes excellence in federal IT.
  • Credence President and CEO Prashant Gaur has been named to the Federal 100, which recognizes excellence in federal IT.
  • Prior to Credence, Gaur had the honor to serve as a senior executive at the Pentagon and as president of ACT-IAC.
  • "And we are especially honored to work with our wonderful teammates at Credence – to whom this award really belongs."

Nathan Kuppermann, M.D., M.P.H., named chief academic officer and chair of Pediatrics at Children’s National Hospital

Retrieved on: 
수요일, 3월 13, 2024

Washington, D.C., March 13, 2024 (GLOBE NEWSWIRE) -- Children's National Hospital has appointed Nathan Kuppermann, M.D., M.P.H., as its new executive vice president (EVP), chief academic officer (CAO) and chair of Pediatrics.

Key Points: 
  • Washington, D.C., March 13, 2024 (GLOBE NEWSWIRE) -- Children's National Hospital has appointed Nathan Kuppermann, M.D., M.P.H., as its new executive vice president (EVP), chief academic officer (CAO) and chair of Pediatrics.
  • He comes to Children’s National from UC Davis Health and UC Davis School of Medicine in Sacramento, CA, and will start in September.
  • After a national search, Dr. Kuppermann stood out for his exceptional contributions to clinical and academic research, focusing on pediatric emergency care, and his dedication to mentorship.
  • He completed a pediatrics residency and chief residency at Harbor-UCLA Medical Center and a fellowship in Pediatric Emergency Medicine at Boston Children's Hospital.

Wayne J. Franklin, M.D., F.A.C.C., named senior vice president of the Children’s National Heart Center

Retrieved on: 
수요일, 3월 13, 2024

Washington, D.C., March 13, 2024 (GLOBE NEWSWIRE) -- Children's National Hospital has appointed Wayne J. Franklin, M.D., F.A.C.C., as the new senior vice president (SVP) of the Children’s National Heart Center .

Key Points: 
  • Washington, D.C., March 13, 2024 (GLOBE NEWSWIRE) -- Children's National Hospital has appointed Wayne J. Franklin, M.D., F.A.C.C., as the new senior vice president (SVP) of the Children’s National Heart Center .
  • Dr. Franklin currently serves as co-director, medical director of Quality and endowed chair in the Center for Heart Care and associate director of the Adult Congenital Heart Disease Program at Phoenix Children’s.
  • “I look forward to leading the exceptional Heart Center team at Children’s National, as we contribute to advancing pediatric cardiac care and research,” said Dr. Franklin.
  • “Together with our Heart Center leadership team, he will ensure we’re meeting the highest standards of safety, quality and innovative care for our patients and families.”
    The Children’s National Heart Center is a multidisciplinary center that provides high-quality and innovative pediatric cardiac care.

Global Leaders in Cancer Research and Biotech Join The Mark Foundation for Cancer Research's Scientific Advisory and Industry Advisory Committees

Retrieved on: 
화요일, 4월 2, 2024

NEW YORK, April 2, 2024 /PRNewswire/ -- The Mark Foundation for Cancer Research, a leading nonprofit dedicated to advancing research that transforms the prevention, diagnosis, and treatment of cancer, proudly announces the appointment of new members to its Scientific Advisory and Industry Advisory Committees.

Key Points: 
  • The committee assists the foundation in reviewing its scientific goals and grant applications, as well as providing strategic advice and support for its research programs and investments.
  • "The outstanding researchers on our advisory committees provide invaluable guidance and insight to help steer its programs toward success and impact."
  • "The Mark Foundation's funding of high-risk, high-impact research is essential in the quest to achieve real breakthroughs in cancer research," said Johanna Joyce, PhD.
  • "I am honored to join the Scientific Advisory Committee, to support the next generations of scientists and projects that will revolutionize treatments for patients."

The Bear Institute Pediatric Accelerator Challenge for Kids Winners Announced

Retrieved on: 
목요일, 2월 1, 2024

AUSTIN, Texas, Feb. 1, 2024 /PRNewswire/ -- Oracle Health and Children's National Hospital announced the winners of the third annual Bear Institute Pediatric Accelerator Challenge for Kids (Bear PACK), a start-up competition aimed at fostering digital health innovation for children. The winners – Bend Health Inc., Kismet Health, RareCareNow, and Thynk Inc. – were recognized across four innovation tracks for their efforts to improve child health outcomes, enhance the care experience for patients, families, and clinicians, and reduce the cost of care for patients and health systems.

Key Points: 
  • Oracle Health and Children's National Hospital's annual Bear PACK competition helps advance pediatric digital health innovation, adoption, and access
    AUSTIN, Texas, Feb. 1, 2024 /PRNewswire/ -- Oracle Health and Children's National Hospital announced the winners of the third annual Bear Institute Pediatric Accelerator Challenge for Kids (Bear PACK), a start-up competition aimed at fostering digital health innovation for children.
  • "Bear PACK includes the entire pediatric healthcare community to help close the gap in innovative solutions dedicated to helping children," said Jessica Herstek, M.D., chief medical information officer, Children's National Hospital.
  • "With less than one percent of global digital health funding being allocated for children's health1, the Bear PACK challenge has never felt more important or needed."
  • Bend Health is a national mental health provider for kids and their families designed to increase access, reduce wait times, and decrease costs of pediatric mental healthcare.

Clearway Health Launches Innovative Model to Support Health Systems in Enabling Access to Breakthrough Gene Therapy

Retrieved on: 
화요일, 1월 16, 2024

BOSTON, Jan. 16, 2024 /PRNewswire/ -- Clearway Health, a specialty pharmacy accelerator partnering with hospitals and health systems, has pioneered a model to support hospitals in enabling access to novel gene therapy treatments. The model was used to execute and accelerate payor, legal and procurement processes for Children's National Hospital in Washington, D.C., to treat their first pediatric patient with ZYNTEGLO®, a one-time, potentially curative breakthrough gene therapy treatment for transfusion-dependent beta-thalassemia, a rare blood disorder requiring regular red blood cell transfusions.

Key Points: 
  • BOSTON, Jan. 16, 2024 /PRNewswire/ -- Clearway Health , a specialty pharmacy accelerator partnering with hospitals and health systems, has pioneered a model to support hospitals in enabling access to novel gene therapy treatments.
  • Clearway Health launches innovative model to support health systems in enabling access to breakthrough gene therapy.
  • "Many health systems are not set up to coordinate the procurement of a novel gene therapy.
  • "Clearway Health's framework allowed us to quickly and efficiently address these concerns, positioning our hospital to provide the latest pharmaceutical advancement."

Dr. John N. van den Anker Named New Editor-in-Chief of The Journal of Clinical Pharmacology

Retrieved on: 
목요일, 1월 4, 2024

ASHBURN, Va., Jan. 4, 2024 /PRNewswire/ -- The American College of Clinical Pharmacology® (ACCP) proudly announces the appointment of Dr. John N. van den Anker, MD, PhD, FAAP, FCP, as the new Editor-in-Chief of The Journal of Clinical Pharmacology (JCP).

Key Points: 
  • ASHBURN, Va., Jan. 4, 2024 /PRNewswire/ -- The American College of Clinical Pharmacology® (ACCP) proudly announces the appointment of Dr. John N. van den Anker, MD, PhD, FAAP, FCP, as the new Editor-in-Chief of The Journal of Clinical Pharmacology (JCP).
  • A distinguished neonatal and pediatric clinical pharmacologist, Dr. van den Anker currently holds the Evan and Cindy Jones Endowed Chair of Pediatric Clinical Pharmacology at Children's National Hospital in Washington, DC.
  • With a decade of service on the JCP Editorial Board and an extensive record of publishing, Dr. van den Anker brings unparalleled expertise to his new role.
  • ACCP invites members and the scientific community to welcome Dr. John N. van den Anker and his team, marking a pivotal moment in the ongoing success of The Journal of Clinical Pharmacology.